COMPOSITION FOR TREATING TUBERCULOSIS
medicine. SUBSTANCE: composition contains tuberculostatic preparation rifampicin, target additives the main magnesium carbonate or calcium carbonate, calcium or magnesium stearate, milk sugar and a foundation as cacao butter and beeswax, fatty foundation linoleic foundation, "vitepsol H- 15&quo...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | medicine. SUBSTANCE: composition contains tuberculostatic preparation rifampicin, target additives the main magnesium carbonate or calcium carbonate, calcium or magnesium stearate, milk sugar and a foundation as cacao butter and beeswax, fatty foundation linoleic foundation, "vitepsol H- 15", polyethyleneoxide foundation. Medicinal form of the composition designed as a suppository is of better biological availability of an active substance and high antitubercular activity against the well-known medicinal forms for peroral intake and intravenous injection. It also enables to decrease side effects of rifampicin and prevent the development of pronounced disbacteriosis. EFFECT: higher efficiency of therapy. 8 cl, 4 tbl, 1 dwg, 5 ex |
---|